Deletion of Mfn2 in endothelial cells triggers a mitohormetic response that improves systemic metabolism and healthspan in mice

Endothelial cells (ECs) are key metabolic gatekeepers, yet their role in metabolic health remains unclear. Given their central involvement in energy metabolism, mitochondria are ideally positioned to enable ECs to adapt to ever-changing metabolic requirements. Here, we explore the hypothesis that mitochondrial dynamics proteins in ECs influence whole-body metabolic status. Genetic deficiency of Mfn2 in ECs (Mfn2<sup>iΔEC</sup>), but not of Mfn1<sup>iΔEC</sup>, induces a mitohormetic response in the adipose vasculature, enhancing antioxidant defenses, mitochondrial fitness, and lipid oxidation, ultimately improving metabolic outcomes. Cultured ECs secrete the mitokine growth differentiation factor 15 (GDF15) via a forkhead box O1 (FOXO1)-dependent axis, a response also observed under stress conditions in vivo. Notably, Mfn2<sup>iΔEC</sup> mice exhibited elevated endothelial and circulating GDF15 levels, and neutralization of GDF15 partly attenuated their metabolic benefits. Consistent with mitohormetic activation, Mfn2<sup>iΔEC</sup> mice showed protection against diet-induced obesity and delayed age-related decline. Hence, vascular mitohormetic adaptations emerge as a novel mechanism promoting systemic metabolic health.

Authors

Institutions

Publication Details

Journal
Cell Metabolism
Published
2026-02-17
DOI
https://doi.org/10.1016/j.cmet.2026.01.012
Primary Topic
GDF15 and Related Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Deletion of Mfn2 in endothelial cells triggers a mitohormetic response that improves systemic metabolism and healthspan in mice

Arnaud Obri, Iasim Tahiri, Josep Maria Roncero Vidal, Alícia G. Gómez-Valadés et al.
Cell Metabolism
GDF15 and Related Biomarkers
article

Deletion of Mfn2 in endothelial cells triggers a mitohormetic response that improves systemic metabolism and healthspan in mice

Arnaud Obri, Iasim Tahiri, Josep Maria Roncero Vidal, Alícia G. Gómez-Valadés, Erika Monelli, Júlia Fos-Domènech, Markus Haake, Abdiel Alvarado-Díaz, Claude Knauf, Marc Claret, Pilar Villacampa, Óscar Osorio-Conles, Íñigo Chivite, Sara Ramírez, Francisco Díaz-Castro, Ruben Nogueiras, Katrien De Bock, Xavier Remesar, Macarena Pozo, Francesc Ventura, Anne Abot, Sabrina Genßler, Tamas L. Horvath, Jordi Altirriba, Christine Schuberth-Wagner, Roberta Haddad-Tóvolli, Mariona Graupera, Miriam Toledo, Elena Eyre, Pablo M. Garcia-Rovés, Chloé van Gelder, Pau García-Ramón, Maria Milà-Guasch, Margalida Munar-Gelabert, Jorge Alvarez Luis, José Antonio Valer, Luis Varela, Antonio Zorzano, Mariana Ferreira
article en

Abstract

Endothelial cells (ECs) are key metabolic gatekeepers, yet their role in metabolic health remains unclear. Given their central involvement in energy metabolism, mitochondria are ideally positioned to enable ECs to adapt to ever-changing metabolic requirements. Here, we explore the hypothesis that mitochondrial dynamics proteins in ECs influence whole-body metabolic status. Genetic deficiency of Mfn2 in ECs (Mfn2<sup>iΔEC</sup>), but not of Mfn1<sup>iΔEC</sup>, induces a mitohormetic response in the adipose vasculature, enhancing antioxidant defenses, mitochondrial fitness, and lipid oxidation, ultimately improving metabolic outcomes. Cultured ECs secrete the mitokine growth differentiation factor 15 (GDF15) via a forkhead box O1 (FOXO1)-dependent axis, a response also observed under stress conditions in vivo. Notably, Mfn2<sup>iΔEC</sup> mice exhibited elevated endothelial and circulating GDF15 levels, and neutralization of GDF15 partly attenuated their metabolic benefits. Consistent with mitohormetic activation, Mfn2<sup>iΔEC</sup> mice showed protection against diet-induced obesity and delayed age-related decline. Hence, vascular mitohormetic adaptations emerge as a novel mechanism promoting systemic metabolic health.

Cell MetabolismVol. 38(3)
Universidade da Coruña (ES), University of Geneva (CH), Université Toulouse III - Paul Sabatier (FR), Inserm (FR), Bellvitge University Hospital (ES), Yale University (US), ETH Zurich (CH), Institut d'Investigació Biomédica de Bellvitge (ES), Josep Carreras Leukaemia Research Institute (ES), Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES), Center for Research in Molecular Medicine and Chronic Diseases (ES), Institut de Recherche en Santé Digestive (FR), Instituto de Investigación Sanitaria de Santiago (ES), Max Planck Institute of Biochemistry (DE), Instituto de Investigación Biomédica de A Coruña (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Universitat de Barcelona (ES)
Openalex Percentile: Top 54%
GDF15 and Related Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.